The preliminary results of a small US study of patients with relapsing remitting multiple sclerosis suggest a combination of the oestrogen hormone estriol and Copaxone, a drug used to treat relapsing forms of the disease, may improve symptoms.
[link url=http://www.medicalnewstoday.com/articles/276203.php]Full Medical News Today report[/link]
MedicalBrief is Africa’s authoritative weekly digest of medical matters, both on the continent and around the world. It brings you a succinct summary of the latest developments, both in news and research, with links to the original material. Contact us: info@medicalbrief.co.za
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
